Hepatitis C: Treatment triumphs

Nature

Volumn 510, Issue 7503, 2014, Pages 43-44

  Rice, Charles M ^a   Saeed, Mohsan ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; PEGINTERFERON; RIBAVIRIN; SOFOSBUVIR;

DISEASE CONTROL; DISEASE TREATMENT; DRUG DEVELOPMENT; HEPATITIS; RESEARCH AND DEVELOPMENT; VIRAL DISEASE;

DRUG INDUSTRY; HEPATITIS A; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; PRIORITY JOURNAL; RISK FACTOR; RNA VIRUS; SHORT SURVEY; TREATMENT DURATION; VIRUS REPLICATION; VIRUS RESISTANCE;

ADMINISTRATION, ORAL; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; HEPACIVIRUS; HEPATITIS C; HUMANS; INTERFERON TYPE I; RIBAVIRIN; URIDINE MONOPHOSPHATE;

EID: 84901911155     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/510043a     Document Type: Short Survey

References (15)

1. Prince, A. M. et al. Lancet 2, 241-246 (1974).
2. Alter, H. J. et al. Lancet 2, 838-841 (1975).
3. Choo, Q. L. et al. Science 244, 359-362 (1989).
4. Mohd Hanafiah, K., Groeger, J., Flaxman, A. D. & Wiersma, S. T. Hepatology 57, 1333-1342 (2013).
5. Feld, J. J. et al. N. Engl. J. Med. 370, 1594-1603 (2014).
6. Afdhal, N. et al. N. Engl. J. Med. 370, 1889-1898 (2014).
7. Afdhal, N. et al. N. Engl. J. Med. 370, 1483-1493 (2014).
8. Kowdley, K. V. et al. N. Engl. J. Med. 370, 222-232 (2014).
9. Kowdley, K. V. et al. N. Engl. J. Med. 370, 1879-1888 (2014).
10. Zeuzem, S. et al. N. Engl. J. Med. 370, 1604-1614 (2014).
11. Sulkowski, M. S., Jacobson, I. M. & Nelson, D. R. N. Engl. J. Med. 370, 1560-1561 (2014).
12. Heim, M. H. Nature Rev. Immunol. 13, 535-542 (2013).
13. Lawitz, E. et al. N. Engl. J. Med. 368, 1878-1887 (2013).
14. Denniston, M. M., Klevens, R. M., McQuillan, G. M. & Jiles, R. B. Hepatology 55, 1652-1661 (2012).
15. Dore, G. J., Ward, J. & Thursz, M. J. Viral Hepat. 21 (suppl. 1) 1-4 (2014).